GARS1 and neuropathy: Our findings demonstrate the pathogenic role of SIRT2‐dependent α‐tubulin deacetylation in mutant GARS‐induced neuropathies and provide new possibilities for targeting SIRT2 as a potential therapy against hereditary axonopathies.